Top Markets
Coin of the day
Kringle Pharma, Inc. Kringle Pharma, Inc.

Kringle Pharma, Inc.

4884
Rangering i aksjer #29210
Kringle Pharma, Inc. specializes in the innovation, production, and... Kringle Pharma, Inc. specializes in the innovation, production, and distribution of hepatocyte growth factor (HGF) protein-based therapeutics aimed at regenerative medicine. The company's cutting-edge HGF solutions are designed to address serious medical conditions including acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scars, and acute kidney injury. Founded in 2001, Kringle Pharma operates from its base in Ibaraki, Japan.
Aksjekurs
$2.77
Markedsverdi
$22.40M
Endring (1 dag)
-0.93%
Endring (1 år)
-17.48%
Land
JP
Handel Kringle Pharma, Inc. (4884)

Kategori

Aksjeprishistorikk for Kringle Pharma, Inc. (4884)
Høyeste sluttskurs: $2.62 den 2026-08-01

Laveste sluttskurs: $12.59 den 2020-12-01
Aksjeprishistorikk for Kringle Pharma, Inc. fra 2020 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 8.04%
2025 -54.41%
2024 6.61%
2023 27.74%
2022 -30.15%
2021 -54.62%
2020 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH